Here, we target CD44+ cancer caner stem/progenitor cells with salinomycin resulting in suppress of EMT and metastasis, which has recently been documented to effectively eliminate caner stem/progenitor cells in different types of human cancers in vitro and in xenograft mice bearing human cancers [36-39]. Here, CD44 is linked to cancer.